Genzyme, the Maker of Cerdelga, a Drug That Treats a Genetic

Genzyme, the maker of Cerdelga, a drug that treats a genetic illness called Gaucher disease that affects 10,000 people worldwide, has been criticized for charging up to $300,000 for a year's worth of Cerdelga. This is an example of the manufacturer adhering to its

A) utopian responsibility.
B) moral idealism.
C) social responsibility.
D) cause marketing strategy.
E) profit responsibility.